Aims and Objectives To construct a path model addressing influences of diabetes distress, self‐efficacy of injecting insulin, resilience and decisional balance of injecting insulin to quality of life (QoL) in insulin‐treated patients with type 2 diabetes (T2DM). Background Insulin regimens more negatively impact QoL than oral medication treatments in patients with T2DM. Understanding the factors and influencing pathways associated with subsequent QoL will help nurses design timely interventions to improve QoL of insulin‐treated T2DM patients. Design A 9‐month prospective design was employed in this study. Methods Self‐reported questionnaires were used to collect data from 185 insulin‐treated T2DM patients. At baseline, diabetes distress and self‐efficacy of injecting insulin were collected, while QoL, resilience and decisional balance of injecting insulin were collected 9 months later. Data were collected from February 2017 to February 2018. Structural equation modelling was used for analysis. This study was conducted based on the STROBE. Results Low baseline diabetes distress and high 9‐month decisional balance of injecting insulin directly associated with high 9‐month QoL. High baseline self‐efficacy of injecting insulin and high 9‐month resilience directly associated with high 9‐month decisional balance of insulin injection and indirectly associated with high 9‐month QoL. High baseline diabetes distress directly and indirectly associated with poor 9‐month QoL. Conclusions Diabetes distress, self‐efficacy of injecting insulin, resilience and decisional balance of injecting insulin play different roles in associating with QoL in insulin‐treated T2DM patients. Relevance to clinical practice Nurses could provide educational programs focusing on enhancing decisional balance of injecting insulin to improve QoL in insulin‐treated patients. Improving self‐efficacy of injecting insulin and resilience could be promising strategies to improve the decisional balance of injecting insulin. More timely assessment of diabetes distress and intervention might be powerful strategies to improve subsequent QoL in these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.